Smith Scott W, Massey Blaine L, Hall Michael B, Buckingham Edward D
Smith Facial Plastics, Gahanna, Ohio.
Advanced ENT & Allergy, Sewell, New Jersey.
Facial Plast Surg. 2024 Jun;40(3):363-369. doi: 10.1055/a-2102-4796. Epub 2023 May 30.
This study aimed to prospectively evaluate the effectiveness, patient satisfaction, and early adverse events of using the hyaluronic acid filler VYC-20L for the treatment of infraorbital hollowing. A total of 21 participants underwent injection of VYC-20L. FACE-Q satisfaction surveys before and after treatment along with early adverse events surveys were conducted. Pre- and posttreatment photos were graded, and the Allergan Infraorbital Hollows Scale was used to assess the difference in infraorbital hollowing. The results showed infraorbital hollowing improvement with VYC-20L was significant ( < 0.001). FACE-Q Satisfaction with Eyes scores on average were 27 points higher after treatment ( < 0.001). The mean FACE-Q Satisfaction with Decision score was 74.1%. The most common short-term adverse symptoms were tenderness (67%), swelling (62%), and bruising (52%). This study concludes that VYC-20L is an effective nonsurgical treatment option for infraorbital hollowing with high patient satisfaction.
本研究旨在前瞻性评估使用透明质酸填充剂VYC - 20L治疗眶下凹陷的有效性、患者满意度及早期不良事件。共有21名参与者接受了VYC - 20L注射。进行了治疗前后的FACE - Q满意度调查以及早期不良事件调查。对治疗前后的照片进行评分，并使用艾尔建眶下凹陷量表评估眶下凹陷的差异。结果显示，使用VYC - 20L后眶下凹陷改善显著（<0.001）。治疗后，FACE - Q眼部满意度平均提高27分（<0.001）。FACE - Q决策满意度平均得分为74.1%。最常见的短期不良症状为压痛（67%）、肿胀（62%）和瘀斑（52%）。本研究得出结论，VYC - 20L是治疗眶下凹陷的一种有效的非手术治疗选择，患者满意度高。
